Tripartite meeting in gene and cell therapy, 2008: Irish Society for Gene and Cell Therapy, British Society for Gene Therapy, and International Society for Cell and Gene Therapy of Cancer.
Authors
Guinn, Barbara-AnnCasey, Garrett
Collins, Sara A.
O'Brien, Tim
Alexander, M. Yvonne
Tangney, Mark
Affiliation
King's College LondonIssue Date
2008-10
Metadata
Show full item recordAbstract
The second annual meeting of the Irish Society for Gene and Cell Therapy was held in Cork, Ireland on May 15 and 16, 2008 (http://crr.ucc.ie/isgct/). The meeting was jointly organized with the British Society for Gene Therapy and the International Society for Cell and Gene Therapy of Cancer. Because of the location of the conference and the co-organization of this meeting with the British and International Gene Therapy societies, the meeting enjoyed a range of talks from some of the major leaders in the field. Particularly notable were the talented molecular and cell biologists from Ireland who have contributed cutting edge science to the field of gene therapy. Topics including cardiovascular disease, repair of single-gene disorders, and cancer gene therapy were discussed with presentations ranging from basic research to translation into the clinic. Here we describe some of the most exciting presentations and their potential impact on imminent clinical gene therapy trials.Citation
Guinn, B.A., Casey, G., Collins, S.A., O'Brien, T., Alexander, M.Y., Tangney, M. (2008) 'Tripartite meeting in gene and cell therapy, : Irish Society for Gene and Cell Therapy, British Society for Gene Therapy, and International Society for Cell and Gene Therapy of Cancer' Human gene therapy 19 (10):967-78Publisher
Mary Ann LiebertJournal
Human gene therapyPubMed ID
18652546Additional Links
http://online.liebertpub.com/doi/abs/10.1089/hum.2008.085Type
ArticleLanguage
enISSN
1557-7422ae974a485f413a2113503eed53cd6c53
10.1089/hum.2008.085
Scopus Count
Collections
Related articles
- International Society for Cell and Gene Therapy of Cancer 2009 Annual Meeting held in Cork, Ireland.
- Authors: Guinn B, Casey G, Möller MG, Kasahara N, O'Sullivan GC, Peng KW, Tangney M
- Issue date: 2010 Jan
- Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer.
- Authors: Balwit JM, Kalinski P, Sondak VK, Coulie PG, Jaffee EM, Gajewski TF, Marincola FM
- Issue date: 2011 May 12
- The NCI All Ireland Cancer Conference.
- Authors: Johnston PG, Daly PA, Liu E
- Issue date: 1999
Related items
Showing items related by title, author, creator and subject.
-
Identification and validation of targets for cancer immunotherapy: from the bench-to-bedsideKhan, Ghazala; Brooks, Suzanne E.; Denniss, Frances; Sigurdardottir, Dagmar; Guinn, Barbara-Ann; University of Bedfordshire; University of Southampton; King’s College London; University of Tübingen (InTech OpenAccess, 2013)
-
Family systemic therapy in the home : reigniting the fireJude, Julia (University of BedfordshireUniversity of Bedfordshire, 2013)The current models that we use in systemic family therapy came out of office/clinic-based practice. To date, there is no model specifically orientated to systemic family therapy in the home. As a systemic family therapist, I argue that non-traditional approaches may need to be considered; and that systemic family therapy models should come closer to reflecting discourses that have shades of global influences. My interest in the area emerged from a position of ignorance – making assumptions that the tools used in the clinic could easily be colonised into a family’s home – but I found that the models often used in the clinic do not necessarily transfer easily into the home. an adaptation of a systematic review was conducted that undermined the notion that therapists are ‘knowing’ with particular skill and competency to work in the home. I ask the question: How do I improve upon my systemic family therapy practice to work in families’ homes? African oral traditional ideas (AOTI) are broadly explored to consider the notion of self and bodily feelings as a source of knowledge. Through the use of AOTI I created an approach known as Seselelame, foregrounding a new practice stemming from ideas that are not home grown within the systemic family therapy perspectives, to support my practice within the home. the inquiry offers the following contribution of new knowledge to family systemic therapy: conceptualization of a method (Seselelame) that incorporates the idea of self in the context of awareness of feelings in the body; a method that incorporates African oral traditional ideas and thus expanded the traditional Western view of family/systemic therapy; contextualization of the significance of home as a source of knowledge; the Seselelame model was used as an analytical tool alongside a systemic constructionist analytical model to compare and contrast the data produced. The findings conclude that the inquiry has implications for the practice and teaching of systemic family therapy, which will eventually be published once the thesis is completed.
-
The innovative evolution of cancer gene and cellular therapiesLam, P.; Khan, Ghazala; Stripecke, R.; Hui, K.M.; Kasahara, N.; Peng, Kah-Whye; Guinn, Barbara-Ann (Nature Publishing Group, 2013-02-01)We provide an overview of the latest developments in cancer gene therapy--from the bench to early-stage clinical trials. We describe the most recent work of worldwide teams including experienced scientists and clinicians, reflecting the recent emergence of gene therapy from the 'Valley of Death'. The treatment efficacy of clinical gene therapy has now been shown in a number of diseases including cancer and we are observing a renewed interest by big pharmaceutical and biotechnology companies most obviously demonstrated by Amgen's acquisition of Biovex for up to USD$1 billion. There is an opportunity to be cautiously hopeful regarding the future of gene therapy in the clinic and we review here some of the most recent progress in the field.